These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10893076)

  • 1. Ganciclovir delivery through an intravitreal microdialysis probe in rabbit.
    Waga J
    Acta Ophthalmol Scand; 2000 Jun; 78(3):369-71. PubMed ID: 10893076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreous disposition of two acycloguanosine antivirals in the albino and pigmented rabbit models: a novel ocular microdialysis technique.
    Hughes PM; Krishnamoorthy R; Mitra AK
    J Ocul Pharmacol Ther; 1996; 12(2):209-24. PubMed ID: 8773936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose intravitreal ganciclovir injection provides a prolonged therapeutic intraocular concentration.
    Morlet N; Young S; Naidoo D; Graham G; Coroneo MT
    Br J Ophthalmol; 1996 Mar; 80(3):214-6. PubMed ID: 8703858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis.
    Kunou N; Ogura Y; Yasukawa T; Kimura H; Miyamoto H; Honda Y; Ikada Y
    J Control Release; 2000 Aug; 68(2):263-71. PubMed ID: 10925134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
    Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug targeting in cytomegalovirus retinitis. Intravitreal implantation of ganciclovir drug carriers].
    Gümbel HO; Koch FH
    Ophthalmologe; 1998 Jan; 95(1):58-63. PubMed ID: 9531804
    [No Abstract]   [Full Text] [Related]  

  • 8. Scleral plug of biodegradable polymers containing ganciclovir for experimental cytomegalovirus retinitis.
    Sakurai E; Matsuda Y; Ozeki H; Kunou N; Nakajima K; Ogura Y
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2043-8. PubMed ID: 11481270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, physicochemical properties and ocular pharmacokinetics of thermosensitive in situ hydrogels for ganciclovir in cytomegalovirus retinitis treatment.
    Wang Q; Sun C; Xu B; Tu J; Shen Y
    Drug Deliv; 2018 Nov; 25(1):59-69. PubMed ID: 29228826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganciclovir implant in the treatment of cytomegalovirus retinitis.
    Chang M; Dunn JP
    Expert Rev Med Devices; 2005 Jul; 2(4):421-7. PubMed ID: 16293081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of bilateral cytomegalovirus retinitis with sustained-release ganciclovir implants in a child.
    Malley DS; Barone R; Heinemann MH
    Am J Ophthalmol; 1996 Nov; 122(5):731-2. PubMed ID: 8909217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained release intravitreal ganciclovir implant as salvage treatment in AIDS related cytomegalovirus retinitis.
    Kamal A; King A; Sylvestri G; Dhillon B
    Br J Ophthalmol; 1998 Mar; 82(3):333. PubMed ID: 9602643
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intravitreal endoscopic visualization of intraocular ganciclovir devices: improved long-term treatment of CMV retinitis].
    Koch FH; Gümbel HO; Hattenbach LO; Ohrloff C
    Klin Monbl Augenheilkd; 1999 Feb; 214(2):107-11. PubMed ID: 10218205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclodialysis complicating intravitreal ganciclovir implantation.
    Gentile RC; Lewis JM; Puklin JE
    Arch Ophthalmol; 1997 Sep; 115(9):1204-5. PubMed ID: 9298069
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravitreal sustained-release ganciclovir implants for severe bilateral cytomegalovirus retinitis after stem cell transplantation.
    Ghosh F; Hansson LJ; Bynke G; Békássy AN
    Acta Ophthalmol Scand; 2002 Feb; 80(1):101-4. PubMed ID: 11906315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications after implantation of intraocular devices in patients with cytomegalovirus retinitis.
    Guembel HO; Krieglsteiner S; Rosenkranz C; Hattenbach LO; Koch FH; Ohrloff C
    Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):824-9. PubMed ID: 10502057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose intravitreal ganciclovir and foscarnet for cytomegalovirus retinitis.
    Velez G; Roy CE; Whitcup SM; Chan CC; Robinson MR
    Am J Ophthalmol; 2001 Mar; 131(3):396-7. PubMed ID: 11239885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganciclovir intraocular implant.
    Morley MG; Duker JS; Reichel E
    Ophthalmology; 1996 Oct; 103(10):1517. PubMed ID: 8874416
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of cytomegalovirus retinitis with intraocular implants.
    Costabile BS
    AORN J; 1998 Feb; 67(2):356-60, 362-5, 368; quiz 369-72. PubMed ID: 9505118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy.
    Kuppermann BD; Quiceno JI; Flores-Aguilar M; Connor JD; Capparelli EV; Sherwood CH; Freeman WR
    J Infect Dis; 1993 Dec; 168(6):1506-9. PubMed ID: 8245536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.